Clinical manifestations of disordered microcirculatory perfusion in severe sepsis
Stephen Trzeciak, Emanuel P Rivers, Stephen Trzeciak, Emanuel P Rivers
Abstract
Microcirculatory dysfunction plays a pivotal role in the development of the clinical manifestations of severe sepsis. Prior to the advent of new imaging technologies, clinicians had been limited in their ability to assess the microcirculation at the bedside. Clinical evidence of microcirculatory perfusion has historically been limited to physical examination findings or surrogates that could be derived from global parameters of oxygen transport. This review explores: (1) the clinical manifestations of severe sepsis that can be linked to microcirculatory dysfunction; (2) the relationship between conventional hemodynamic parameters and microcirculatory blood flow indices; (3) the incorporation of microcirculatory function into the definition of 'shock' in the sepsis syndrome; (4) the role of the microcirculation in oxygen transport; and (5) the potential impact of novel sepsis therapies on microcirculatory flow. Although the study of the microcirculation has long been the domain of basic science, newly developed imaging technologies, such as orthogonal polarization spectral imaging, have now given us the ability to directly visualize and analyze microcirculatory blood flow at the bedside, and see the microcirculatory response to therapeutic interventions. Disordered microcirculatory flow can now be associated with systemic inflammation, acute organ dysfunction, and increased mortality. Using new technologies to directly image microcirculatory blood flow will help define the role of microcirculatory dysfunction in oxygen transport and circulatory support in severe sepsis.
Figures
References
- De Backer D, Creteur J, Preiser JC, Dubois MJ, Vincent JL. Microvascular blood flow is altered in patients with sepsis. Am J Respir Crit Care Med. 2002;166:98–104. doi: 10.1164/rccm.200109-016OC.
- Spronk PE, Ince C, Gardien MJ, Mathura KR, Oudemans-van Straaten HM, Zandstra DF. Nitroglycerin in septic shock after intravascular volume resuscitation. Lancet. 2002;360:1395–1396. doi: 10.1016/S0140-6736(02)11393-6.
- Sakr Y, Dubois MJ, De Backer D, Creteur J, Vincent JL. Persistent microcirculatory alterations are associated with organ failure and death in patients with septic shock. Crit Care Med. 2004;32:1825–1831. doi: 10.1097/01.CCM.0000138558.16257.3F.
- Bateman RM, Sharpe MD, Ellis CG. Bench-to-bedside review: microvascular dysfunction in sepsis – hemodynamics, oxygen transport, and nitric oxide. Crit Care. 2003;7:359–373. doi: 10.1186/cc2353.
- Rivers E, Nguyen B, Havstad S, Ressler J, Muzzin A, Knoblich B, Peterson E, Tomlanovich M. Early Goal-Directed Therapy Collaborative Group. Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med. 2001;345:1368–1377. doi: 10.1056/NEJMoa010307.
- Aird WC. The role of the endothelium in severe sepsis and multiple organ dysfunction syndrome. Blood. 2003;101:3765–3777. doi: 10.1182/blood-2002-06-1887.
- Yan SB, Helterbrand JD, Hartman DL, Wright TJ, Bernard GR. Low levels of protein C are associated with poor outcome in severe sepsis. Chest. 2001;120:915–922. doi: 10.1378/chest.120.3.915.
- Ince C. Microcirculation in distress: a new resuscitation end point? Crit Care Med. 2004;32:1963–1964. doi: 10.1097/01.CCM.0000139617.88704.B9.
- Vincent J-L, De Backer D. Microvascular dysfunction as a cause of organ dysfunction in severe sepsis. Critical Care. 2005;9(suppl 4):S9–S12.
- Dellinger RP. Cardiovascular management of septic shock. Crit Care Med. 2003;31:946–955. doi: 10.1097/01.CCM.0000057403.73299.A6.
- Nguyen HB, Rivers EP, Knoblich BP, Jacobsen G, Muzzin A, Ressler JA, Tomlanovich MC. Early lactate clearance is associated with improved outcome in severe sepsis and septic shock. Crit Care Med. 2004;32:1637–1642. doi: 10.1097/01.CCM.0000132904.35713.A7.
- Wo CC, Shoemaker WC, Appel PL, Bishop MH, Kram HB, Hardin E. Unreliability of blood pressure and heart rate to evaluate cardiac output in emergency resuscitation and critical illness. Crit Care Med. 1993;21:218–223.
- LeDoux D, Astiz ME, Carpati CM, Rackow EC. Effects of perfusion pressure on tissue perfusion in septic shock. Crit Care Med. 2000;28:2729–2732. doi: 10.1097/00003246-200008000-00007.
- Bourgoin A, Leone M, Delmas A, Garnier F, Albanese J, Martin C. Increasing mean arterial pressure in patients with septic shock: effects on oxygen variables and renal function. Crit Care Med. 2005;33:780–786. doi: 10.1097/01.CCM.0000157788.20591.23.
- Donnino MW, Nguyen HB, Jacobsen G, Tomlanovich M, Rivers EP. Cryptic septic shock: a sub-analysis of early goal-directed therapy [abstract] Chest. 2003;124:90S. doi: 10.1378/chest.124.1.90.
- Dellinger RP, Carlet JM, Masur H, Gerlach H, Calandra T, Cohen J, Gea-Banacloche J, Keh D, Marshall JC, Parker MM. Surviving Sepsis Campaign Management Guidelines Committee et al.Surviving sepsis campaign guidelines for management of severe sepsis and septic shock. Crit Care Med. 2004;32:858–873. doi: 10.1097/01.CCM.0000117317.18092.E4.
- Vincent JL, Abraham E, Annane D, Bernard G, Rivers E, Van den Berghe G. Reducing mortality in sepsis: new directions. Crit Care. 2002;6(suppl 3):S1–18. doi: 10.1186/cc1860.
- Trzeciak S. Lac-time? Crit Care Med. 2004;32:1785–1786. doi: 10.1097/01.CCM.0000134837.18530.14.
- Aduen J, Bernstein WK, Khastgir T, Miller J, Kerzner R, Bhatiani A, Lustgarten J, Bassin AS, Davison L, Chernow B. The use and clinical importance of a substrate-specific electrode for rapid determination of blood lactate concentrations. JAMA. 1994;272:1678–1685. doi: 10.1001/jama.272.21.1678.
- Bakker J, Coffernils M, Leon M, Gris P, Vincent JL. Blood lactate levels are superior to oxygen-derived variables in predicting outcome in human septic shock. Chest. 1991;99:956–962.
- Bakker J, Gris P, Coffernils M, Kahn RJ, Vincent JL. Serial blood lactate levels can predict the development of multiple organ failure following septic shock. Am J Surg. 1996;171:221–226. doi: 10.1016/S0002-9610(97)89552-9.
- Spronk PE, Zandstra DF, Ince C. Bench-to-bedside review: sepsis is a disease of the microcirculation. Crit Care. 2004;8:462–468. doi: 10.1186/cc2894.
- Krogh A. The number and the distribution of capillaries in muscle with the calculation of the oxygen pressure necessary for supplying tissue. J Physiol. 1919;52:409–515.
- Ellsworth ML, Pittman RN. Arterioles supply oxygen to capillaries by diffusion as well as by convection. Am J Physiol. 1990;258:H1240–H1243.
- Beal AL, Cerra FB. Multiple organ failure syndrome in the 1990s. Systemic inflammatory response and organ dysfunction. JAMA. 1994;271:226–233. doi: 10.1001/jama.271.3.226.
- Karimova A, Pinsky DJ. The endothelial response to oxygen deprivation: biology and clinical implications. Intensive Care Med. 2001;27:19–31. doi: 10.1007/s001340000790.
- Fink MP. Bench-to-bedside review: Cytopathic hypoxia. Crit Care. 2002;6:491–499. doi: 10.1186/cc1824.
- Ince C, Sinaasappel M. Microcirculatory oxygenation and shunting in sepsis and shock. Crit Care Med. 1999;27:1369–1377. doi: 10.1097/00003246-199907000-00031.
- Rivers EP, Rady MY, Martin GB, Fenn NM, Smithline HA, Alexander ME, Nowak RM. Venous hyperoxia after cardiac arrest. Characterization of a defect in systemic oxygen utilization. Chest. 1992;102:1787–1793.
- Rivers EP, Wortsman J, Rady MY, Blake HC, McGeorge FT, Buderer NM. The effect of the total cumulative epinephrine dose administered during human CPR on hemodynamic, oxygen transport, and utilization variables in the postresuscitation period. Chest. 1994;106:1499–1507.
- Macias WL, Yan SB, Williams ND, Um SL, Sandusky GE, Ballard DW, Planquois J-MS. New insights into the protein C pathway: potential implications for the biological activities of drotrecogin alfa (activated) Critical Care. 2005;9(suppl 4):S38–S45.
- Buwalda M, Ince C. Opening the microcirculation: can vasodilators be useful in sepsis? Intensive Care Med. 2002;28:1208–1217. doi: 10.1007/s00134-002-1407-2.
- De Backer D, Berre J, Zhang H, Kahn RJ, Vincent JL. Relationship between oxygen uptake and oxygen delivery in septic patients: effects of prostacyclin versus dobutamine. Crit Care Med. 1993;21:1658–1664.
- Pittet JF, Lacroix JS, Gunning K, Laverriere MC, Morel DR, Suter PM. Prostacyclin but not phentolamine increases oxygen consumption and skin microvascular blood flow in patients with sepsis and respiratory failure. Chest. 1990;98:1467–1472.
- Bihari D, Smithies M, Gimson A, Tinker J. The effects of vasodilation with prostacyclin on oxygen delivery and uptake in critically ill patients. N Engl J Med. 1987;317:397–403.
- Radermacher P, Buhl R, Santak B, Klein M, Kniemeyer HW, Becker H, Tarnow J. The effects of prostacyclin on gastric intramucosal pH in patients with septic shock. Intensive Care Med. 1995;21:414–421. doi: 10.1007/BF01707410.
- Secchi A, Wellmann R, Martin E, Schmidt H. Dobutamine maintains intestinal villus blood flow during normotensive endotoxemia: an intravital microscopic study in the rat. J Crit Care. 1997;12:137–141. doi: 10.1016/S0883-9441(97)90043-5.
- Duranteau J, Sitbon P, Teboul JL, Vicaut E, Anguel N, Richard C, Samii K. Effects of epinephrine, norepinephrine, or the combination of norepinephrine and dobutamine on gastric mucosa in septic shock. Crit Care Med. 1999;27:893–900. doi: 10.1097/00003246-199905000-00021.
- Shoemaker WC, Appel PL, Kram HB. Hemodynamic and oxygen transport effects of dobutamine in critically ill general surgical patients. Crit Care Med. 1986;14:1032–1037.
- De Backer D, Dubois MJ, Creteur J, Sakr Y, Vincent JL. Microcirculatory alterations are an independent outcome predictor in patients with severe sepsis and septic shock [abstract] Crit Care Med. 2003;31:A117.
Source: PubMed